Atomic structure of a rationally engineered gene delivery vector, AAV2.5

被引:20
|
作者
Burg, Matthew [1 ]
Rosebrough, Claire [1 ]
Drouin, Lauren M. [1 ,6 ]
Bennett, Antonette [1 ]
Mietzsch, Mario [1 ]
Chipman, Paul [1 ]
McKenna, Robert [1 ]
Sousa, Duncan [2 ]
Potter, Mark [3 ,4 ]
Byrne, Barry [3 ,4 ]
Samulski, R. Jude [5 ]
Agbandje-McKenna, Mavis [1 ]
机构
[1] Univ Florida, Coll Med, Dept Biochem & Mol Biol, McKnight Brain Inst, Gainesville, FL 32610 USA
[2] Florida State Univ, Dept Biol Sci, Biol Sci Imaging Resource, 89 Chieftan Way,Rm 119, Tallahassee, FL 32306 USA
[3] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA
[4] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA
[5] Univ N Carolina, Dept Pharmacol, Gene Therapy Ctr, Chapel Hill, NC 27515 USA
[6] Voyager Therapeut Inc, Cambridge, MA USA
关键词
Adeno-associated virus; cryo-EM; Vector engineering; Structure-guided design; Parvovirus; THERAPY; TRANSDUCTION; INSIGHTS; BINDING; CELLS; MODEL;
D O I
10.1016/j.jsb.2018.05.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
AAV2.5 represents the first structure-guided in-silica designed Adeno-associated virus (AAV) gene delivery vector. This engineered vector combined the receptor attachment properties of AAV serotype 2 (AAV2) with the muscle tropic properties of AAV1, and exhibited an antibody escape phenotype because of a modified antigenic epitope. To confirm the design, the structure of the vector was determined to a resolution of 2.78 angstrom using cryo-electron microscopy and image reconstruction. The structure of the major viral protein (VP), VP3, was ordered from residue 219 to 736, as reported for other AAV structures, and the five AAV2.5 residues exchanged from AAV2 to AAV1, Q263A, T265 (insertion), N706A, V709A, and T717N, were readily interpretable. Significantly, the surface loops containing these residues adopt the AAV1 conformation indicating the importance of amino acid residues in dictating VP structure.
引用
收藏
页码:236 / 241
页数:6
相关论文
共 50 条
  • [21] Engineered CHO cells as a novel AAV production platform for gene therapy delivery
    Nagy, Abdou
    Chakrabarti, Lina
    Kurasawa, James
    Mulagapati, Sri Hari Raju
    Devine, Paul
    Therres, Jamy
    Chen, Zhongying
    Schmelzer, Albert E.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [22] Engineered CHO cells as a novel AAV production platform for gene therapy delivery
    Abdou Nagy
    Lina Chakrabarti
    James Kurasawa
    Sri Hari Raju Mulagapati
    Paul Devine
    Jamy Therres
    Zhongying Chen
    Albert E. Schmelzer
    Scientific Reports, 13
  • [23] Correction of Neurological Manifestations of Mucopolysaccharidosis IIIC by a Novel Rationally Designed Neurotropic AAV Gene Therapy Vector
    O'Leary, Claire
    Antunes, Andre
    Tordo, Julie
    Liao, Ai Yin
    Gleitz, Helene
    Parker, Helen
    Holley, Rebecca
    Youshani, Amir Saam
    Stacey, Kevin
    Davis, Daniel
    Dridi, Larbi
    Martins, Carla
    Pshezhetsky, Alexey
    Linden, Michael
    Henckaerts, Els
    Bigger, Brian
    MOLECULAR THERAPY, 2017, 25 (05) : 244 - 244
  • [24] Exosome-containing AAV significantly improves gene delivery in comparing the conventical AAV vector in vitro
    Liu, Dage
    Tokunaga, Yoshimasa
    Nakashima, Nariyasu
    Nakano, Takayuki
    Zhang, Xia
    Yajima, Toshiki
    CANCER SCIENCE, 2024, 115 : 1981 - 1981
  • [25] Recombinant AAV-mediated gene delivery using dual vector heterodimerization
    Yan, ZY
    Ritchie, YC
    Duan, DS
    Engelhardt, JF
    GENE THERAPY METHODS, 2002, 346 : 334 - 357
  • [26] Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice
    Iwata, Nobuhisa
    Sekiguchi, Misaki
    Hattori, Yoshino
    Takahashi, Akane
    Asai, Masashi
    Ji, Bin
    Higuchi, Makoto
    Staufenbiel, Matthias
    Muramatsu, Shin-ichi
    Saido, Takaomi C.
    SCIENTIFIC REPORTS, 2013, 3
  • [27] Continued In Vitro and In Vivo Characterization of Novel AAV Vectors Engineered for Muscle Gene Delivery
    Green, Jennifer
    Willacy, Tiffany
    Boehler, Jessica
    Dhruva, Alina
    Meng, Hui
    Beatka, Margaret
    Ott, Emily
    Prom, Mariah
    Lawlor, Michael W.
    Pechan, Peter
    Morris, Carl
    MOLECULAR THERAPY, 2021, 29 (04) : 159 - 159
  • [28] AAV vectors engineered to target insulin receptor greatly enhance intramuscular gene delivery
    Jackson, Cody B.
    Richard, Audrey S.
    Ojha, Amrita
    Conkright, Kimberly A.
    Trimarchi, Jeffrey M.
    Bailey, Charles C.
    Alpert, Michael D.
    Kay, Mark A.
    Farzan, Michael
    Choe, Hyeryun
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 19 : 496 - 506
  • [29] Adeno-associated virus (AAV) as a gene delivery vector for liver cells
    Lau, JYN
    Muzyczka, N
    HEPATOLOGY, 1997, 26 (04) : 273 - 273
  • [30] Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice
    Nobuhisa Iwata
    Misaki Sekiguchi
    Yoshino Hattori
    Akane Takahashi
    Masashi Asai
    Bin Ji
    Makoto Higuchi
    Matthias Staufenbiel
    Shin-ichi Muramatsu
    Takaomi C. Saido
    Scientific Reports, 3